what is noom glp-1 Retention, Renewal, Results: Noom's GLP‑1 Companion Noom Unveils Microdose GLP-1 Program
Description
no major safety concerns were observed
Glucagon-like peptide 1 receptor agonists (GLP1-RA) are indicated for the treatment of type 2 diabetes and more recently for weight loss
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health issues.
Multivariate analysis showed no difference between placebo and liraglutide arms in HbA1c at 6 months (HbA1c:0.2mmol/mol, 11.3, 11.6, p=0.98) however, at 12 months HbA1c was significantly higher in the liraglutide arm (HbA1c:10.9mmol/mol, 1.1, 20.6, p=0.032)
Potency test
Alcohol is not contraindicated on GLP-1 but amplifies nausea, low blood sugar, and dehydration
